Target intelligence / Profile preview

Endoplasmic reticulum lectin 1 (ERLEC1)

Target
ERLEC1
Molecular classification
Lectin, Endoplasmic reticulum-associated degradation (ERAD) cofactor, Unfolded protein binder, glycoprotein recognition protein
01

Overview

Endoplasmic reticulum lectin 1 (ERLEC1) is a resident ER protein that binds to unfolded or misfolded glycoproteins through recognition of N-linked glycans, serving a critical function in ER-associated degradation (ERAD), which eliminates defective proteins from the secretory pathway. It interacts as part of multi-protein complexes to facilitate the transport and disposal of aberrant glycoproteins, thus maintaining cellular proteostasis; dysregulation of ERLEC1 or ERAD components is implicated in diseases featuring protein misfolding and aggregation, including neurodegenerative conditions and cancer. ERLEC1 is widely expressed, notably residing in the endoplasmic reticulum lumen, and although its role in disease is under investigation, it is regarded as a molecular cofactor and potential target in ER stress-associated pathologies.

Other names
ERLEC1C2orf30CIMCL24936CL25084HEL117XTP3-BXTP3TPBEndoplasmic reticulum lectin 1ERLECTINXTP3-transactivated gene B protein
02

Biological functions

Unfolded protein bindingQuality control of secretory pathway proteinsN-glycan recognitionER-associated degradation (ERAD) of misfolded proteinsRegulation of glycoprotein traffickingNegative regulation of retrograde transport, ER to cytosol
03

Disease associations

Dysregulation may contribute to protein misfolding diseases (e.g., neurodegeneration, cancer) although direct links to specific diseases are not fully establishedCancer

Beyond the preview

Go deeper on Endoplasmic reticulum lectin 1 (ERLEC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum lectin 1 (ERLEC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call